Stay updated with breaking news from Edwin Lefevre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kotak strategists Sanjeev Prasad, Anindya Bhowmik and Sunita Baldawa are unsure if most PSU stocks will see meaningful earnings upgrades over the coming 12-24 months, to be able to justify the high valuations
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
Nine out of ten people feel that valuations of many mid, small and micro cap shares have become irrational
Cipla, Jubilant in focus on Street, while petchem companies run into a rough patch
Vedanta, Mankind Pharma in focus, Nykaa on a rally, as market harps on capex story